TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 37.0 Cr.
- Current Price ₹ 49.4
- High / Low ₹ 79.5 / 39.3
- Stock P/E
- Book Value ₹ 36.4
- Dividend Yield 0.00 %
- ROCE -7.04 %
- ROE -6.55 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Debtor days have improved from 175 to 96.4 days.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -10.6% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from -337 days to 100 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
0.40 | 0.92 | 4.23 | 3.55 | 7.35 | 32.23 | 32.07 | |
1.26 | 1.75 | 5.11 | 7.56 | 11.01 | 34.45 | 33.57 | |
Operating Profit | -0.86 | -0.83 | -0.88 | -4.01 | -3.66 | -2.22 | -1.50 |
OPM % | -215.00% | -90.22% | -20.80% | -112.96% | -49.80% | -6.89% | -4.68% |
0.04 | 1.15 | 1.23 | -1.69 | 0.02 | 0.43 | 0.45 | |
Interest | 0.12 | 0.01 | 0.01 | 0.01 | 0.28 | 0.16 | 0.08 |
Depreciation | 0.00 | 0.01 | 0.03 | 0.17 | 0.37 | 0.30 | 0.33 |
Profit before tax | -0.94 | 0.30 | 0.31 | -5.88 | -4.29 | -2.25 | -1.46 |
Tax % | 0.00% | 0.00% | 61.29% | 0.00% | -0.70% | 1.78% | |
-0.95 | 0.30 | 0.12 | -5.88 | -4.27 | -2.29 | -1.49 | |
EPS in Rs | -1.27 | 0.40 | 0.16 | -6.85 | -5.35 | -2.61 | -1.57 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 141% |
3 Years: | 97% |
TTM: | 78% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 74% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 10% |
3 Years: | 11% |
1 Year: | 7% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -6% |
3 Years: | -11% |
Last Year: | -7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 |
Reserves | 29.02 | 29.07 | 29.19 | 21.93 | 23.26 | 21.31 | 19.76 |
5.38 | 5.64 | 5.83 | 6.53 | 1.44 | 0.27 | 0.15 | |
31.35 | 27.33 | 29.32 | 29.58 | 36.63 | 54.74 | 54.23 | |
Total Liabilities | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 81.62 |
58.01 | 58.01 | 58.82 | 55.28 | 35.70 | 17.28 | 9.11 | |
CWIP | 0.00 | 0.00 | 0.06 | 0.02 | 0.10 | 0.10 | 0.00 |
Investments | 0.44 | 0.19 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
10.70 | 7.24 | 8.68 | 6.14 | 33.01 | 66.42 | 72.51 | |
Total Assets | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 81.62 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-1.63 | -0.57 | 0.39 | -4.21 | -10.87 | 1.95 | |
0.01 | 0.00 | -0.51 | 4.22 | 5.84 | -0.64 | |
5.32 | -3.14 | 0.18 | 0.19 | 4.87 | -1.30 | |
Net Cash Flow | 3.69 | -3.70 | 0.06 | 0.20 | -0.15 | 0.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.35 | 232.90 | 96.37 |
Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.66 | 852.04 |
Days Payable | 2,581.07 | 1,914.85 | 743.59 | 77.21 | 91.78 | 78.57 |
Cash Conversion Cycle | 274.18 | -360.73 | -58.24 | 310.47 | 410.78 | 869.84 |
Working Capital Days | -6,077.25 | -1,023.59 | -314.95 | -691.96 | -419.13 | 100.11 |
ROCE % | 0.82% | -0.16% | -10.58% | -12.90% | -7.04% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
16 Dec - Received work order for 250 KWp solar power plant.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
16 Dec - Received work order for 250 KWp solar power plant.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Copies of Newspaper clippings regarding Unaudited Consolidated and Standalone Financial Results for the Quarter ended 30th September 2024 published on Wednesday, 13th November 2024 in …
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2024 And The Consolidated And Standalone Unaudited Financial Results Along With Consolidated And Standalone Limited Review Reports For The Quarter And Period Ended 30Th September 2024
12 Nov - Approval of Q2 FY2024 financial results by Board.
-
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For Quarter Ended 30Th September 2024
1 Nov - Board meeting on November 12 to approve Q2 results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants